ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 144 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2021. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $183,000 | -56.1% | 15,205 | -22.8% | 0.00% | – |
Q2 2021 | $417,000 | -56.7% | 19,705 | -42.6% | 0.00% | -100.0% |
Q1 2021 | $963,000 | +7.8% | 34,345 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $893,000 | -59.6% | 34,345 | -42.2% | 0.00% | -66.7% |
Q3 2020 | $2,209,000 | -29.2% | 59,425 | -2.2% | 0.00% | -25.0% |
Q2 2020 | $3,118,000 | +117.9% | 60,751 | +33.8% | 0.00% | +100.0% |
Q1 2020 | $1,431,000 | -39.9% | 45,404 | +13.7% | 0.00% | 0.0% |
Q4 2019 | $2,381,000 | +90.8% | 39,922 | +28.5% | 0.00% | +100.0% |
Q1 2019 | $1,248,000 | -36.7% | 31,078 | -28.5% | 0.00% | -50.0% |
Q4 2018 | $1,972,000 | -33.8% | 43,467 | -35.2% | 0.00% | -33.3% |
Q3 2018 | $2,977,000 | +13.2% | 67,105 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $2,630,000 | +61.9% | 67,105 | +198.9% | 0.00% | +50.0% |
Q1 2018 | $1,624,000 | -32.5% | 22,451 | -78.0% | 0.00% | -33.3% |
Q3 2015 | $2,407,000 | -55.1% | 102,020 | +55.7% | 0.00% | -50.0% |
Q2 2015 | $5,359,000 | -11.2% | 65,540 | +0.6% | 0.01% | -14.3% |
Q1 2015 | $6,034,000 | +331.6% | 65,167 | +88.5% | 0.01% | +250.0% |
Q4 2014 | $1,398,000 | – | 34,567 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 2,679,835 | $69,675,000 | 19.39% |
Endurant Capital Management LP | 207,293 | $5,390,000 | 1.94% |
Bellevue Group AG | 5,138,451 | $133,599,000 | 1.53% |
Rhenman & Partners Asset Management AB | 592,225 | $15,398,000 | 1.26% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,562,869 | $40,635,000 | 0.93% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 31,434 | $817,000 | 0.62% |
WASATCH ADVISORS LP | 3,998,010 | $103,949,000 | 0.51% |
HAMILTON LANE ADVISORS LLC | 46,181 | $1,201,000 | 0.45% |
Boxer Capital, LLC | 500,000 | $13,000,000 | 0.42% |
DCF Advisers, LLC | 38,500 | $1,001,000 | 0.41% |